MELISSA SMITH: Open Payments
NPI 1598151169 · HERNANDO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 20 payments from 8 companies in 2025. Trend: 2023 $898 · 2024 $333 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 5 | $82 |
| IDORSIA PHARMACEUTICALS US INC | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Tris Pharma Inc | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
Products named: Jornay PM, Quviviq, REXULTI, VRAYLAR, SPRAVATO, Auvelity, Dyanavel XR, FANAPT.
Industry payments across MS — which companies pay providers there.
